Aytu BioPharma Inc (AYTU)
2.84
+0.04
(+1.43%)
USD |
NASDAQ |
Apr 25, 16:00
2.86
+0.02
(+0.70%)
After-Hours: 20:00
Aytu BioPharma Free Cash Flow (Quarterly): -0.135M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.135M |
September 30, 2023 | -0.211M |
June 30, 2023 | 9.365M |
March 31, 2023 | -2.906M |
December 31, 2022 | -2.44M |
September 30, 2022 | -9.148M |
June 30, 2022 | -7.095M |
March 31, 2022 | -9.115M |
December 31, 2021 | -8.822M |
September 30, 2021 | -3.791M |
June 30, 2021 | -6.277M |
March 31, 2021 | -8.78M |
December 31, 2020 | -2.924M |
September 30, 2020 | -7.983M |
June 30, 2020 | -7.765M |
March 31, 2020 | -11.52M |
December 31, 2019 | -6.099M |
September 30, 2019 | -2.988M |
June 30, 2019 | -3.474M |
Date | Value |
---|---|
March 31, 2019 | -3.357M |
December 31, 2018 | -4.310M |
September 30, 2018 | -2.751M |
June 30, 2018 | -4.543M |
March 31, 2018 | -4.141M |
December 31, 2017 | -3.113M |
September 30, 2017 | -4.218M |
June 30, 2017 | -3.327M |
March 31, 2017 | -2.401M |
December 31, 2016 | -2.876M |
September 30, 2016 | -5.337M |
June 30, 2016 | -2.714M |
March 31, 2016 | -2.464M |
December 31, 2015 | -3.572M |
September 30, 2015 | -2.161M |
June 30, 2015 | |
March 31, 2015 | |
February 28, 2015 | -0.0134M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.52M
Minimum
Mar 2020
9.365M
Maximum
Jun 2023
-4.848M
Average
-6.099M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
Regen BioPharma Inc | -0.2093M |
Clearday Inc | -0.559M |
Bioxytran Inc | -0.0816M |
Shuttle Pharmaceuticals Holdings Inc | -1.062M |
CEL-SCI Corp | -4.953M |